Efficacy and Safety of Abatacept Combined With JAK Inhibitor for Refractory Rheumatoid Arthritis
Clinical trial NCT05451615 · UNKNOWN
Trial details
- NCT number
- NCT05451615
- Sponsor
- Zhejiang Provincial People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2023-06-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.